Second Sight Medical Products Inc (NASDAQ:EYES) Director Gregg Williams acquired 26,483 shares of the business’s stock in a transaction that occurred on Tuesday, September 11th. The shares were bought at an average price of $1.68 per share, for a total transaction of $44,491.44. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Gregg Williams also recently made the following trade(s):

  • On Thursday, September 13th, Gregg Williams acquired 31,750 shares of Second Sight Medical Products stock. The shares were bought at an average price of $1.65 per share, for a total transaction of $52,387.50.
  • On Friday, September 7th, Gregg Williams acquired 15,875 shares of Second Sight Medical Products stock. The shares were bought at an average price of $1.73 per share, for a total transaction of $27,463.75.
  • On Wednesday, September 5th, Gregg Williams acquired 30,828 shares of Second Sight Medical Products stock. The shares were bought at an average price of $1.69 per share, for a total transaction of $52,099.32.
  • On Friday, August 31st, Gregg Williams acquired 31,750 shares of Second Sight Medical Products stock. The shares were bought at an average price of $1.72 per share, for a total transaction of $54,610.00.
  • On Wednesday, August 29th, Gregg Williams acquired 15,720 shares of Second Sight Medical Products stock. The shares were bought at an average price of $1.61 per share, for a total transaction of $25,309.20.
  • On Monday, August 27th, Gregg Williams acquired 10,623 shares of Second Sight Medical Products stock. The shares were bought at an average price of $1.57 per share, for a total transaction of $16,678.11.
  • On Thursday, August 23rd, Gregg Williams acquired 17,052 shares of Second Sight Medical Products stock. The shares were bought at an average price of $1.63 per share, for a total transaction of $27,794.76.
  • On Monday, August 20th, Gregg Williams acquired 4,110 shares of Second Sight Medical Products stock. The shares were bought at an average price of $1.57 per share, for a total transaction of $6,452.70.
  • On Friday, August 17th, Gregg Williams acquired 7,800 shares of Second Sight Medical Products stock. The shares were bought at an average price of $1.56 per share, for a total transaction of $12,168.00.
  • On Wednesday, August 15th, Gregg Williams acquired 3,247,362 shares of Second Sight Medical Products stock. The shares were bought at an average price of $1.55 per share, for a total transaction of $5,033,411.10.

NASDAQ:EYES opened at $1.72 on Friday. The stock has a market cap of $107.99 million, a P/E ratio of -2.92 and a beta of 3.09. Second Sight Medical Products Inc has a 52-week low of $1.05 and a 52-week high of $2.58.

Second Sight Medical Products (NASDAQ:EYES) last released its earnings results on Tuesday, August 7th. The medical device company reported ($0.12) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.14) by $0.02. The firm had revenue of $1.91 million for the quarter, compared to analyst estimates of $2.21 million. Second Sight Medical Products had a negative return on equity of 432.45% and a negative net margin of 418.82%. analysts anticipate that Second Sight Medical Products Inc will post -0.58 EPS for the current year.

A number of brokerages recently weighed in on EYES. Zacks Investment Research upgraded shares of Second Sight Medical Products from a “sell” rating to a “hold” rating in a research note on Thursday, September 6th. HC Wainwright set a $5.00 price objective on shares of Second Sight Medical Products and gave the company a “buy” rating in a research note on Wednesday, August 8th.

About Second Sight Medical Products

Second Sight Medical Products, Inc, together with its subsidiaries, develops, manufactures, and markets prosthetic devices to restore functional vision of blind individuals in the United States, Canada, Europe, the Middle East, and Asia. It offers Argus II System, which treats outer retinal degenerations, such as retinitis pigmentosa.

Read More: What is intrinsic value?

Insider Buying and Selling by Quarter for Second Sight Medical Products (NASDAQ:EYES)

Receive News & Ratings for Second Sight Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Second Sight Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.